- Category
- Small (2021-22)
- Udyam number
- UDYAM-TS-09-0026119

Apigran Pharma Private Limited
About Apigran Pharma Private Limited
Data last updated:
Apigran Pharma Private Limited is a private limited company based in Patancheru, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 December 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2021PTC158179. Its GSTIN is 36AAWCA2931M1Z4 (Telangana).
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹1 Lakh. It is led by directors including Kruti Nishit Kadakia and Lavanya Yerram.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 5 & 6/31 Ida Phase II, Patancheru, Telangana, India – 502324.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.11 Lakh, a decline of 37% compared to the previous year. For the same year it recorded a net loss of ₹57.56 Lakh and EBITDA of -₹51.2 Lakh.
As per MCA filings, the company has open charges of ₹14.55 Cr on record.
Apigran Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0026119). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Apigran Pharma
Contact details
Apigran Pharma Private Limited's registered office is in Patancheru, Telangana.
- Registered AddressPlot No 5 & 6/31 Ida Phase II, Patancheru, Telangana, India – 502324
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Apigran Pharma Private Limited
FY 2025 filings availableApigran Pharma Private Limited reported revenue of ₹2.11 Lakh (down 37% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 37% in the latest year. EBITDA fell 58% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹51.2 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹57.56 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Apigran Pharma Private Limited, buy the company report.
Board of directors of Apigran Pharma Private Limited
Apigran Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kruti Nishit Kadakia Also directs: Rewas Technologies Private Limited, Skysea Ventures LLP | Director | 22 Dec 2021 | 4 Years 10 Months | Current |
| Lavanya Yerram | Director | 22 Dec 2021 | 4 Years 10 Months | Current |
| Nishit Prakash Chandra Kadakia Also directs: Biotris Biologics Private Limited, Synzyme Lifesciences Private Limited, Shruti Drugs Private Limited and 4 more | Director | 01 Apr 2024 | 2 Years 7 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Aug 2022 | 100607077 | Others | ₹14.55 Cr | Open |
To see the full charge records of Apigran Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Apigran Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Apigran Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Apigran Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAWCA2931M1Z4 | Telangana | Active | 04 Mar 2022 |
To see the full GST registrations and return filing status of Apigran Pharma Private Limited, buy the company report.
Recent activity
Apigran Pharma Private Limited has 4 board changes on record since 2021: 3 appointments and 1 cessation. The latest: Nishit Prakash Chandra Kadakia ceased to be Additional Director on 29 Sep 2025.
Frequently asked questions
Apigran Pharma is an active private limited company based in Patancheru, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 December 2021 (5+ years old) and is registered under CIN U24290TG2021PTC158179.
Apigran Pharma has 3 current directors:
- Kruti Nishit Kadakia - Director
- Lavanya Yerram - Director
- Nishit Prakash Chandra Kadakia - Director
The latest financial statements of Apigran Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Apigran Pharma is 36AAWCA2931M1Z4, registered in Telangana.
The CIN (Corporate Identification Number) of Apigran Pharma is U24290TG2021PTC158179. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apigran Pharma was incorporated on 22 December 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
Nishit Prakash Chandra Kadakia ceased to be Additional Director on 29 Sep 2025. Nishit Prakash Chandra Kadakia was appointed as Director on 01 Apr 2024. Kruti Nishit Kadakia was appointed as Director on 22 Dec 2021. Apigran Pharma has 4 board changes on record in total.
Yes, Apigran Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-TS-09-0026119).
The registered office of Apigran Pharma is at Plot No 5 & 631 Ida Phase II, Patancheru, Telangana, India – 502324.
Apigran Pharma operates in the pharma industry, in the drug formulation and development segment.

